These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32047267)

  • 41. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells.
    van Deutekom JC; Bremmer-Bout M; Janson AA; Ginjaar IB; Baas F; den Dunnen JT; van Ommen GJ
    Hum Mol Genet; 2001 Jul; 10(15):1547-54. PubMed ID: 11468272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intronic Alternative Polyadenylation in the Middle of the
    Rani AQM; Yamamoto T; Kawaguchi T; Maeta K; Awano H; Nishio H; Matsuo M
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional analysis of variants in DMD exon/intron 10 predicted to affect splicing.
    Zhang X; Chen X; Chen J; Ma Y; Huang S; Cai M; Wang L; Yi L
    J Hum Genet; 2022 Aug; 67(8):495-501. PubMed ID: 35428841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe cardiac involvement with preserved truncated dystrophin expression in Becker muscular dystrophy by +1G>A DMD splice-site mutation: a case report.
    Komaki R; Hashimoto Y; Mori-Yoshimura M; Oya Y; Takizawa H; Minami N; Nishino I; Aoki Y; Takahashi Y
    J Hum Genet; 2020 Oct; 65(10):903-909. PubMed ID: 32504006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induced dystrophin exon skipping in human muscle explants.
    McClorey G; Fall AM; Moulton HM; Iversen PL; Rasko JE; Ryan M; Fletcher S; Wilton SD
    Neuromuscul Disord; 2006 Oct; 16(9-10):583-90. PubMed ID: 16919955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A commentary on a novel splicing silencer generated by DMD exon 45 deletion junction could explain upstream exon 44 skipping that modifies dystrophinopathy.
    Ishikawa Y
    J Hum Genet; 2014 Aug; 59(8):419-20. PubMed ID: 24990311
    [No Abstract]   [Full Text] [Related]  

  • 47. Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene.
    Errington SJ; Mann CJ; Fletcher S; Wilton SD
    J Gene Med; 2003 Jun; 5(6):518-27. PubMed ID: 12797117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort.
    Flanigan KM; Dunn DM; von Niederhausern A; Soltanzadeh P; Gappmaier E; Howard MT; Sampson JB; Mendell JR; Wall C; King WM; Pestronk A; Florence JM; Connolly AM; Mathews KD; Stephan CM; Laubenthal KS; Wong BL; Morehart PJ; Meyer A; Finkel RS; Bonnemann CG; Medne L; Day JW; Dalton JC; Margolis MK; Hinton VJ; ; Weiss RB
    Hum Mutat; 2009 Dec; 30(12):1657-66. PubMed ID: 19937601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systemic Delivery of Morpholinos to Skip Multiple Exons in a Dog Model of Duchenne Muscular Dystrophy.
    Maruyama R; Echigoya Y; Caluseriu O; Aoki Y; Takeda S; Yokota T
    Methods Mol Biol; 2017; 1565():201-213. PubMed ID: 28364245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel point mutation affecting Asn76 of dystrophin protein leads to dystrophinopathy.
    Koczok K; Merő G; Szabó GP; Madar L; Gombos É; Ajzner É; Mótyán JA; Hortobágyi T; Balogh I
    Neuromuscul Disord; 2018 Feb; 28(2):129-136. PubMed ID: 29373175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel splice site mutation (3157+1G>T) in the dystrophin gene causing total exon skipping and DMD phenotype.
    Sironi M; Corti S; Locatelli F; Cagliani R; Comi GP
    Hum Mutat; 2001 Mar; 17(3):239. PubMed ID: 11241855
    [No Abstract]   [Full Text] [Related]  

  • 52. Dystrophinopathy caused by mid-intronic substitutions activating cryptic exons in the DMD gene.
    Béroud C; Carrié A; Beldjord C; Deburgrave N; Llense S; Carelle N; Peccate C; Cuisset JM; Pandit F; Carré-Pigeon F; Mayer M; Bellance R; Récan D; Chelly J; Kaplan JC; Leturcq F
    Neuromuscul Disord; 2004 Jan; 14(1):10-8. PubMed ID: 14659407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antisense Oligonucleotide Treatment in a Humanized Mouse Model of Duchenne Muscular Dystrophy and Highly Sensitive Detection of Dystrophin Using Western Blotting.
    Maruyama R; Yokota T
    Methods Mol Biol; 2021; 2224():203-214. PubMed ID: 33606217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathological Issues in Dystrophinopathy in the Age of Genetic Therapies.
    Shahnoor N; Siebers EM; Brown KJ; Lawlor MW
    Annu Rev Pathol; 2019 Jan; 14():105-126. PubMed ID: 30148687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In silico screening based on predictive algorithms as a design tool for exon skipping oligonucleotides in Duchenne muscular dystrophy.
    Echigoya Y; Mouly V; Garcia L; Yokota T; Duddy W
    PLoS One; 2015; 10(3):e0120058. PubMed ID: 25816009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptional and epigenetic analyses of the DMD locus reveal novel cis‑acting DNA elements that govern muscle dystrophin expression.
    Gherardi S; Bovolenta M; Passarelli C; Falzarano MS; Pigini P; Scotton C; Neri M; Armaroli A; Osman H; Selvatici R; Gualandi F; Recchia A; Mora M; Bernasconi P; Maggi L; Morandi L; Ferlini A; Perini G
    Biochim Biophys Acta Gene Regul Mech; 2017 Nov; 1860(11):1138-1147. PubMed ID: 28867298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Becker muscular dystrophy caused by an intronic mutation reducing the efficiency of the splice donor site of intron 26 of the dystrophin gene.
    Baskin B; Banwell B; Khater RA; Hawkins C; Ray PN
    Neuromuscul Disord; 2009 Mar; 19(3):189-92. PubMed ID: 19230662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contributions of Japanese patients to development of antisense therapy for DMD.
    Matsuo M; Takeshima Y; Nishio H
    Brain Dev; 2016 Jan; 38(1):4-9. PubMed ID: 26094594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exon skipping therapy for Duchenne muscular dystrophy.
    Kole R; Krieg AM
    Adv Drug Deliv Rev; 2015 Jun; 87():104-7. PubMed ID: 25980936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urine mRNA to identify a novel pseudoexon causing dystrophinopathy.
    Antoury L; Hu N; Darras B; Wheeler TM
    Ann Clin Transl Neurol; 2019 Jun; 6(6):1106-1112. PubMed ID: 31211175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.